Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

0.1% Topical Sirolimus in the Treatment of Cutaneous Microcystic Lymphatic Malformations in Children and Adults: Phase II, Split-body Randomized, Double-blind, Vehicle-controlled Clinical Trial

NCT03972592 is registered in ClinicalTrials.gov with University Hospital, Tours as lead sponsor.

NCT NCT03972592
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03972592 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
0.1% Topical Sirolimus in the Treatment of Cutaneous Microcystic Lymphatic Malformations in Children and Adults: Phase II, Split-body Randomized, Double-blind, Vehicle-controlled Clinical Trial
Lead sponsor
University Hospital, Tours
Phase
Phase 2
Overall status
Completed
Start date
June 5, 2019
Completion date
August 14, 2024
Enrollment
55 (actual)
Sites
17

Conditions

As the registry lists them; a condition with its own page is linked.

lymphatic malformation, vascular malformations